BASS XXIII Tutorials and Keynote Address presentations: Search: SessionSpeakerPresentation Keynote AddressJanet WittesLearning from Extroverts, or Assuming Statistical Leadership M-2Kao-Tai Tsai Joint Modeling of Time-to-and Laboratory Test Data Trial M-3Richard ZinkUncovering Fraud, Misconduct and Other Data Quality Issues in Clinical Trials M-4Vance BergerComparable comparison Groups in Randomized Clinical Trials M-5Dungang LiuMeta-analysis of Rare Events in Drug Safety Studies: A Unifying Framework for Exact Inference M-6Gheorghe DorosClinical Trial Designs for Placebo Response in Clinical Trials for Psychiatric Disorders M-7William R. PruckaInnovative Designs and Analyses for Pediatric Drug Development Keynote AddressRalph B. D'Agostino, Sr.Comments and Reflections on Issues in Clinical Trials:Both Design and Analysis:Past, Present and Future T-2Bohdana RatitchAnalysis Strategies for Clinical Trials with Treatment Non-Adherence T-3Gerhardt Pohl, Anthony ZagarReal World Evidence-Generalizability and Propensity Scoring T-4Mat D. DavisCurrent and Future States of the DIA Bayesian Scientific Working Group Education Effort T-5Shankar Srinivasan, Vatsala KarweTepee Plots: A Novel Statistical Descriptive Graphical Technique for Representating Tabular Data T-6Steven Gilbert, Zorayr ManukyanBayesian Dynamic Borrowing W-1Yi Ysong and Meiyu Shen Analytical Biosimilar Assessment: Current Practice and Draft Guidance, Three Biosimilar Advisory Committee Meetings & Analytical Biosimilar Assessment: Frequently Discussed Statistical Issues W-2ShanMei Liao, Bo Jin, Yi Tsong, Meiyu Shen and Cassie(Xiaoyu) Dong Tipping Point Analysis- Considerations for Missing Data in Biosimilars & Biosimilars ← 2015 2017 →
